Pharmaceutical Dosage Forms

1.	Dosage Forms as Drug Delivery Systems
2.	Routes of Administration
2.1.	Parenteral Administration
2.2.	Oral Administration
2.3.	Dermal Administration
2.4.	Rectal Administration
2.5.	Other Routes of Administration
3.	Types of Dosage Forms
3.1.	Liquid Solution Dosage Forms
3.1.1.	Solutions
3.1.2.	Extractive Solutions
3.1.3.	Parenteral Solutions (Injections)
3.1.4.	Inhalations
3.1.5.	Ophthalmic and Nasal Solutions (Drops)
3.1.6.	Otic Solutions
3.1.7.	Liniments
3.1.8.	Enemas and Douches
3.1.9.	Mouthwashes and Gargles
3.1.10.	Collodions
3.1.11.	Soaps and Shampoos
3.2.	Liquid Dispersions
3.2.1.	Emulsions
3.2.2.	Suspension
3.2.3.	Foams
3.2.4.	Sprays
3.3.	Semisolid Dosage Forms
3.3.1.	Gels, Magmas, and Mucilages
3.3.2.	Ointments, Creams, Pastes, and Plasters
3.4.	Plastic Dosage Forms
3.4.1.	Suppositories
3.4.2.	Inserts
3.4.3.	Implants
3.4.4.	Pellets
3.5.	Solid Dosage Forms
3.5.1.	Bulk Powders and Effervescent Powders
3.5.2.	Dusting Powders
3.5.3.	Insufflations
3.5.4.	Lyophilized Powders
3.5.5.	Capsules
3.5.6.	Cachets
3.5.7.	Pills
3.5.8.	Tablet Triturates, Hypodermic Tablets
3.5.9.	Troches and Lozenges
3.5.10.	Gums
3.5.11.	Films
3.5.12.	Strips
3.5.13.	Tapes
3.5.14.	Granules
3.5.15.	Compressed Tablets
3.6.	Prolonged-Action Dosage Forms
3.7.	Pressurized Aerosol Dosage Forms
3.8.	Nonpressurized Gaseous Dosage Forms (Inhalants)
3.9.	Radiopharmaceutical Dosage Forms
4.	Active Pharmaceutical Ingredients (APIs)
4.1.	Hydrates and Solvates
4.2.	Organic Salts
4.3.	Esters
4.4.	Inorganic Salts
4.5.	Potency-Designated Ingredients
4.6.	Complex Organic Molecules
4.7.	Aliquots, Dilutions, and Concentrates
4.8.	Product Quality Tests
5.	Pharmaceutical Excipients
5.1.	Formulation Excipients
5.2.	Patient Compliance Excipients
5.3.	Stability Excipients
6.	Quality Assurance
7.	Pharmaceutical Containers
8.	Development of the Ideal Drug Delivery System
8.1.	Controlled-Release Drug Delivery Systems
8.2.	Sustained- or Prolonged-Release Technology
8.2.1.	Oral Sustained-Release Dosage Forms
8.2.2.	Other Sustained- and Prolonged-Release Drug Delivery Systems
8.3.	Targeted Drug Delivery Systems

References

1 L.V. Allen Jr, H.C. Ansel: “ Dosage Form Design: Pharmaceutical and Formulation Considerations”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 102–104.
Google Scholar
2 R.I. Mahato, A.S. Narang: Pharmaceutical Dosage Forms and Drug Delivery, 2nd ed., CRC Press, New York 2012, pp. 15–16.
Google Scholar
3 A. Desai and M. Lee: Gibaldi's Drug Delivery Systems in Pharmaceutical Care, American Society of Health-Systems Pharmacists, Bethesda 2007, pp. 3–9.
Web of Science® Google Scholar
4 L.V. Allen Jr, H.C. Ansel: “ Dosage Form Design: Biopharmaceutical and Pharmacokinetic Considerations”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 166–211.
Web of Science® Google Scholar
5 D.W.A. Bourne: “ Pharmacokinetics” in A.T. Florence, J. Siepman (eds.): Modern Pharmaceutics, 5th ed., vol. 1 Basic Principles and Systems, Informa Healthcare, New York 2009, pp. 81–116.
Google Scholar
6 S.B. Johnson: “ ;Bioavailability and Bioequivalency Testing” in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 349–359.
Google Scholar
7 L.V. Allen Jr, H.C. Ansel: “ Routes of Drug Administration”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 187–197.
Google Scholar
8 J.C. Boylan, A.L. Fites: “ Routes of Parenteral Administration” in G.S. Banker, C.T. Rhodes (eds.): Modern Pharmaceutics, 2nd ed., Marcel Dekker, New York 1990, pp. 493–502.
Google Scholar
9 J.C. Boylan, S.L. Nail: “ Parenteral Products” in A.T. Florence, J. Siepman (eds.): Modern Pharmaceutics, 5th ed., vol. 1 Basic Principles and Systems, Informa Healthcare, New York 2009, pp. 565–609.
Google Scholar
10 S.J. Turco, R.E. King: Sterile Dosage Forms, 3rd ed., Lea & Febiger, Philadelphia 1987, pp. 6, 7.
Google Scholar
11 M.A. Akers: Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality, Informa Healthcare, New York 2010, pp. 1–28.
Web of Science® Google Scholar
12 J.L. Colaizzi, W.H. Pitlick: “ The Oral Route of Administration” in G.S. Banker, R.K. Chalmers (eds.): Pharmaceutics and Pharmacy Practice, J. B. Lippincott, Philadelphia 1982, pp. 184–190.
Google Scholar
13 V.H.L. Lee: “ Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs”, Peptide and Protein Drugs, Marcel Dekker, New York 1990, pp. 1–56.
Google Scholar
14 L.V. Allen Jr, H.C. Ansel: “ Novel Dosage Forms and Drug Delivery Technologies” in: Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia, 2014, pp 735–737.
Google Scholar
15 A.J. Hickey, H.M. Mansour: “ Delivery of Drugs by the Pulmonary Route”, Modern Pharmaceutics, 5th ed., vol. 2, Informa Healthcare, New York 2009, pp. 191–219.
Web of Science® Google Scholar
16 “ Pharmaceutical Dosage Forms” in USP XXII, U. S. Pharmacopeial Convention, Rockville 1990, pp. 1688–1697.
Google Scholar
17 M.M. Crowley: “ Solutions, Emulsions, Suspensions, and Extracts” in L.V. Allen (ed): Remington — The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 801–834.
Web of Science® Google Scholar
18 European Pharmacopoeia 8th ed. (2014), http://www.edqm.eu/en/european-pharmacopoeia-8th-edition-1563.html (accessed 21 August 2014).
Google Scholar
19 The United States Pharmacopeia and the National Formulary, USP 37-NF 32 (2014), http://www.usp.org/usp-nf (accessed 21 August 2014).
Google Scholar
20 J.C. Boylan, S.L. Nail: “ Parenteral Products”, Modern Pharmaceutics, 5th ed.,vol. 1, Informa Healthcare, New York 2009, pp. 565–609.
Google Scholar
21 L.V. Allen Jr, H.C. Ansel: “ Disperse Systems”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 445–506.
Google Scholar
22 J.J. Sciarra, C.J. Sciarra: “ Aerosols” in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 999–1015.
Google Scholar
23 L.V. Allen Jr, H.C. Ansel: “ Suppositories, Inserts, and Sticks”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 364–393.
Web of Science® Google Scholar
24 Y.B. Wang, R.O. Williams III: “ Powders” in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 777–799.
Google Scholar
25 A.A. Sakr, F.K. Alanazi: “ Oral Solid Dosage Forms” in L.V. Allen (ed.): Remington-The Science and Practice of Pharmacy 22nd ed., Pharmaceutical Press, London, 2013, pp. 947–976.
Google Scholar
26 A.A. Sakr; F.K. Alanazi: “ Soft Elastic Capsules” in L.V. Allen (ed.): Remington-The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 974–976.
Google Scholar
27 S.C. Porter: “ Coating of Pharmaceutical Dosage Forms” in L.V. Allen (ed.): Remington — The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 977–987.
Google Scholar
28 L.V. Allen Jr, H.C. Ansel: “ Tablet Coating”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 284–290.
Web of Science® Google Scholar
29 A.R. Rajabi-Siahboomi, M.S. Rane, L.A. Felton: “ Oral Modified-Release Drug Delivery Systems” in L.V. Allen (ed): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 989–998.
Google Scholar
30 J. Siepmann, F. Siepmann: “ Time-Controlled Drug Delivery Systems” in A.T. Florence, J. Siepman (eds.): Modern Pharmaceutics, vol. 1 Basic Principles and Systems, Informa Healthcare, New York 2009, pp. 1–22.
Google Scholar
31 G.M. Grass IV, J.R. Robinson: “ Sustained- and Controlled-Release Drug Delivery Systems” in G.S. Banker, C.T. Rhodes (eds.): Modern Pharmaceutics, 2nd ed., Marcel Dekker, New York 1990, pp. 635–671.
Google Scholar
32 L.V. Allen Jr, H.C. Ansel: “ Solid Oral Modified-Release Dosage Forms and Drug Delivery Systems”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 299–314.
Google Scholar
33 A. Williams: “ Transdermal and Topical Drug Delivery–From Theory to Clinical Practice”, Pharmaceutical Press, London 2003.
Google Scholar
34 Y.W. Chien: “ Transdermal Controlled-Release Drug Administration”, Novel Drug Delivery Systems, Marcel Dekker, New York 1982, pp. 149–218.
Google Scholar
35 “ Ocular Controlled-Release Drug Administration”, Novel Drug Delivery Systems, Marcel Dekker, New York 1982, pp. 13–50.
Google Scholar
36 “ Intravaginal/Intrauterine Controlled-Release Drug Administration”, Novel Drug Delivery Systems, Marcel Dekker, New York 1982, pp. 51–148.
Google Scholar
37 “ Parenteral/Implantable Controlled-Release Drug Delivery Systems”, Novel Drug Delivery Systems, Marcel Dekker, New York 1982, pp. 219–412.
Google Scholar
38 L.V. Allen Jr, H.C. Ansel: “ Aerosols”, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 489–501.
Google Scholar
39 J.P. Norenberg, W.B. Hladik III: “ Fundamentals of Medical Radionuclides” in L.V. Allen (ed.): Remington — The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 195–209.
Google Scholar
40 R.C. Rowe, P.J. Sheskey, W.G. Cook, M.E. Fenton: “ Handbook of Pharmaceutical Excipients”, 7th ed., Pharmaceutical Press, London, 2012.
Google Scholar
41 Anon, “ Pharmaceutical Excipients” in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 1837–1852.
Google Scholar
42 L.V. Allen Jr: “ Flavors, Sweeteners, and Colors”, The Art, Science and Technology of Pharmaceutical Compounding, 4th ed., American Pharmaceutical Association, Washington 2012, pp. 119–129.
Google Scholar
43 W.J. Reilly Jr: “ Pharmaceutical Excipients” in L.V. Allen (ed.): Remington - The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 1049–1052.
Google Scholar
44 M.J. Akers: “ Quality Assurance and Control”, Sterile Drug Products - Formulation, Packaging, Manufacturing, and Quality, Informa-Healthcare, New York 2010, pp. 382–399.
Google Scholar
45 A. Al-Achi, M.R. Gupta, W.C. Stagner: “ Quality Systems and Controls”, Integrated Pharmaceutics, John Wiley & Sons, Inc., Hoboken 2013, pp. 863–909.
Google Scholar
46 J.H. Parker, J.E. Enders: “ Quality Assurance and Control”, in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 327–333.
Web of Science® Google Scholar
47 C.J. Taborsky, K. Deiss: “ Pharmaceutical Packaging”, in L.V. Allen (ed.): Remington–The Science and Practice of Pharmacy, 22nd ed., Pharmaceutical Press, London 2013, pp. 1033–1048.
Google Scholar
48 L.V. Allen Jr, H.C. Ansel: “ Packaging, Labeling, and Storage of Pharmaceuticals” in: Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 88–99.
Google Scholar
49 Pharmaceutical Dosage Forms, in U.S. Pharmacopoeia 37-National Formulary 32, Rockville 2014, pp. 1028–1030.
Google Scholar
50 R. Sareen, N. Jain, D. Kumar: “An insight to osmotic drug delivery”, Curr. Drug Deliv. 9 (May 2012) no. 3, 285–296.
10.2174/156720112800389106
CAS PubMed Web of Science® Google Scholar
51 A. Patel, T. Mehta, J. Patel, M. Patel, K. Patel, N. Patel: “Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview”, Recent Pat Drug Deliv Formul. 6 (April 1, 2012) no. 1, 66–72.
10.2174/187221112799219099
CAS PubMed Google Scholar
52 C. Paderni, D. Compilato, L.I. Giannola, G. Campisi: “Oral local drug delivery and new perspectives in oral drug formulation”, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 114 (Sep. 2012) no. 3, e50–34.
10.1016/j.oooo.2012.02.016
PubMed Web of Science® Google Scholar
53 P.K. Ruby, S.M. Pathak, D. Aggarwal: “Critical attributes of transdermal drug delivery system (TDDS)–a generic product development review”, Drug Dev. Ind. Pharm. 2014, Jan 27.
10.3109/03639045.2013.879720
PubMed Web of Science® Google Scholar
54 H. Gupta, R.J. Babu: “Transdermal delivery: product and patent update”, Recent Pat. Drug Deliv. Formul. 7 (Dec. 2013) no. 3, 184–205.
10.2174/187221130703131128121747
CAS PubMed Google Scholar
55 L.V. Allen Jr, H.C. Ansel: “ Novel Dosage Forms and Drug Delivery Technologies” in: Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 10th ed., Wolters Kluwer, Philadelphia 2014, pp. 726–752.
Google Scholar
56 V. Kumar: “ Target-Oriented Drug Delivery Systems”, in A.T. Florence, J. Siepman (eds.): Modern Pharmaceutics, vol. 1 Basic Principles and Systems, Informa Healthcare, New York 2009, pp. 329–398.
Google Scholar
57 X. Li, M. Yu, W. Fan, Y. Gan, L. Hovgaard, M. Yang: “Orally active-targeted drug delivery systems for proteins and peptides”, Expert Opin. Drug Deliv. 2014, June 25, 1–13.
Google Scholar
58 S. Onoue, S. Yamada, H.K. Chan: “Nanodrugs: pharmacokinetics and safety”, Int J Nanomedicine 9 (Feb. 20, 2014) 1025–1037.
10.2147/IJN.S38378
CAS PubMed Web of Science® Google Scholar
59 S. Mallick, J.S. Choi: “Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery”, J. Nanosci. Nanotechnol. 14 (Jan. 2014) no. 1, 755–765.
10.1166/jnn.2014.9080
CAS PubMed Web of Science® Google Scholar
60 D.L. Cooper, C.M. Conder, S. Harirforoosh: “Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxidity”, Expert Opin. Drug Deliv. 2014, Jul 23, 1–20.
Google Scholar
61 R.I. Mahato, A.S. Narang: “ Particulate Carrier Systems”, Pharmaceutical Dosage Forms and Drug Delivery, 2nd ed., CRC Press, New York 2012, pp. 220–230.
Google Scholar
62 C. Urban, A.S. Urban, H. Charron, A. Joshi: “Externally modulated theranostic nanoparticles”, Transl. Cancer Res. 2 (Aug. 2013) no. 4,; 292–308.
PubMed Web of Science® Google Scholar
63 J. Drbohlavova, J. Chomoucka, V. Adam, M. Ryvolova, T. Eckschlager, J. Hubalek, R. Kizek: “Nanocarriers for anticancer drugs — new trends in nanomedicine”, Curr. Drug Metab. 14 (June 2013) no. 5, 547–564.
10.2174/1389200211314050005
CAS PubMed Web of Science® Google Scholar
64 A.Z. Wilczewska, K. Niemirowicz, K.H. Markiewicz, H. Car: “Nanoparticles as drug delivery systems”, Pharmacol. Rep. 64 (2012) no. 5, 1020–1037.
10.1016/S1734-1140(12)70901-5
CAS PubMed Web of Science® Google Scholar

Citing Literature

Ullmann's Encyclopedia of Industrial Chemistry

Browse other articles of this reference work:

Pharmaceutical Dosage Forms

View previous versions

Pharmaceutical Dosage Forms

Abstract

References

Further Reading

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Pharmaceutical Dosage Forms

View previous versions

Pharmaceutical Dosage Forms

Abstract

References

Further Reading

Citing Literature

References

Related

Information